PPD names new executive vice president and CMO
Prior to joining PPD, Dr Dingivan spent 12 years with MedImmune, a worldwide biologics business acquired by AstraZeneca. Dr Dingivan earned her undergraduate degree in bioengineering from the
AstraZeneca and Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) have signed an exclusive licence agreement for TQC3721.